Cargando…

Exosomes: Biological Carriers and Promising Tools for Cancer Immunotherapy

Detalles Bibliográficos
Autores principales:	Saleh, Reem, Elkord, Eyad
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7565712/ https://www.ncbi.nlm.nih.gov/pubmed/32708564 http://dx.doi.org/10.3390/vaccines8030390

Ejemplares similares

Promising use of immune cell‐derived exosomes in the treatment of SARS‐CoV‐2 infections
por: Alahdal, Murad, et al.
Publicado: (2022)

Editorial of Harnessing the Power of T Cells: The Promising Hope for a Universal Influenza Vaccine
por: Toor, Salman M., et al.
Publicado: (2020)

Non‐coding RNAs in cancer immunotherapy: Predictive biomarkers and targets
por: Alahdal, Murad, et al.
Publicado: (2023)

Role of exosomal ncRNAs released by M2 macrophages in tumor progression of gastrointestinal cancers
por: Meyiah, Abdo, et al.
Publicado: (2023)

Editorial: CD4(+) T Cells in Cancer Immunotherapies
por: González-Navajas, José M., et al.
Publicado: (2021)

Breast Cancer Cells and PD-1/PD-L1 Blockade Upregulate the Expression of PD-1, CTLA-4, TIM-3 and LAG-3 Immune Checkpoints in CD4(+) T Cells
por: Saleh, Reem, et al.
Publicado: (2019)

Role of Epigenetic Modifications in Inhibitory Immune Checkpoints in Cancer Development and Progression
por: Saleh, Reem, et al.
Publicado: (2020)

T-Regulatory Cells in Health and Disease
por: Elkord, Eyad, et al.
Publicado: (2018)

Blockade of PD-1, PD-L1, and TIM-3 Altered Distinct Immune- and Cancer-Related Signaling Pathways in the Transcriptome of Human Breast Cancer Explants
por: Saleh, Reem, et al.
Publicado: (2020)

Transcriptomic Analyses of Myeloid-Derived Suppressor Cell Subsets in the Circulation of Colorectal Cancer Patients
por: Sasidharan Nair, Varun, et al.
Publicado: (2020)

PD-L1 Blockade by Atezolizumab Downregulates Signaling Pathways Associated with Tumor Growth, Metastasis, and Hypoxia in Human Triple Negative Breast Cancer
por: Saleh, Reem, et al.
Publicado: (2019)

Exosome-based immunotherapy: a promising approach for cancer treatment
por: Xu, Zhijie, et al.
Publicado: (2020)

Correction to: Metabolic reprogramming of T regulatory cells in the hypoxic tumor microenvironment
por: Sasidharan Nair, Varun, et al.
Publicado: (2021)

Metabolic reprogramming of T regulatory cells in the hypoxic tumor microenvironment
por: Sasidharan Nair, Varun, et al.
Publicado: (2021)

Bacterial therapy: a promising strategy for cancer immunotherapy
por: Wang, Yinsong
Publicado: (2023)

Mesenchymal Stem Cell–Derived Exosomes: A Promising Biological Tool in Nanomedicine
por: Wei, Wumei, et al.
Publicado: (2021)

T‐cell responses and therapies against SARS‐CoV‐2 infection
por: Toor, Salman M., et al.
Publicado: (2020)

Next-Generation Sequencing: A Promising Tool for Vaccines and Other Biological Products
por: Nellimarla, Srinivas, et al.
Publicado: (2023)

Responsive Dual-Targeting Exosome as a Drug Carrier for Combination Cancer Immunotherapy
por: Fan, Yuanyuan, et al.
Publicado: (2021)

Aptamers: Promising Tools for Cancer Diagnosis and Therapy
por: Cerchia, Laura
Publicado: (2018)

Postbiotics as Promising Tools for Cancer Adjuvant Therapy
por: Homayouni Rad, Aziz, et al.
Publicado: (2021)

Exosomes: A potential tool for immunotherapy of ovarian cancer
por: Gong, Xiangjin, et al.
Publicado: (2023)

Regulatory T Cells in the Tumor Microenvironment and Cancer Progression: Role and Therapeutic Targeting
por: Chaudhary, Belal, et al.
Publicado: (2016)

Identification of two HLA-A*0201 immunogenic epitopes of lactate dehydrogenase C (LDHC): potential novel targets for cancer immunotherapy
por: Thomas, Remy, et al.
Publicado: (2020)

Significance of CD44 and CD24 as Cancer Stem Cell Markers: An Enduring Ambiguity
por: Jaggupilli, Appalaraju, et al.
Publicado: (2012)

Thymus-Derived, Peripherally Derived, and in vitro-Induced T Regulatory Cells
por: Elkord, Eyad
Publicado: (2014)

Helios Should Not Be Cited as a Marker of Human Thymus-Derived Tregs. Commentary: Helios(+) and Helios(−) Cells Coexist within the Natural FOXP3(+) T Regulatory Cell Subset in Humans
por: Elkord, Eyad
Publicado: (2016)

Differential gene expression of tumor-infiltrating CD33(+) myeloid cells in advanced- versus early-stage colorectal cancer
por: Toor, Salman M., et al.
Publicado: (2020)

PARP inhibition and immunotherapy: a promising duo in fighting cancer
por: Phillipps, Jordan, et al.
Publicado: (2023)

Comparison of Myeloid Cells in Circulation and in the Tumor Microenvironment of Patients with Colorectal and Breast Cancers
por: Toor, Salman M., et al.
Publicado: (2017)

Synthetic biology: promises and challenges
por: Serrano, Luis
Publicado: (2007)

Tumor-derived exosomes: the next generation of promising cell-free vaccines in cancer immunotherapy
por: Naseri, Marzieh, et al.
Publicado: (2020)

DNA methylation in the promoters of PD-L1, MMP9, ARG1, galectin-9, TIM-3, VISTA and TGF-β genes in HLA-DR(–) myeloid cells, compared with HLA-DR(+) antigen-presenting cells
por: Saleh, Reem, et al.
Publicado: (2020)

Editorial On “Exosomes, Their Biogenesis and Role in Inter-Cellular Communication, Tumor Microenvironment and Cancer Immunotherapy”
por: Golubovskaya, Vita, et al.
Publicado: (2020)

Myeloid-derived suppressor cells in colorectal cancer: prognostic biomarkers and therapeutic targets
por: Al-Mterin, Mohammad A., et al.
Publicado: (2022)

Downregulation of Immunosuppressive Environment in Patients with Chronic HBV Hepatitis on Maintained Remission
por: Chaudhary, Belal, et al.
Publicado: (2015)

Exhaustion and over-activation of immune cells in COVID-19: Challenges and therapeutic opportunities
por: Alahdal, Murad, et al.
Publicado: (2022)

RNA-Seq Analysis of Colorectal Tumor-Infiltrating Myeloid-Derived Suppressor Cell Subsets Revealed Gene Signatures of Poor Prognosis
por: Saleh, Reem, et al.
Publicado: (2020)

Biological Functions of Exosomes in the Liver in Health and Disease
por: Imani Fooladi, Abbas Ali, et al.
Publicado: (2014)

Increased Levels of Granulocytic Myeloid-Derived Suppressor Cells in Peripheral Blood and Tumour Tissue of Pancreatic Cancer Patients
por: Khaled, Yazan S., et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_gdl6vt6inb0s7sq6l2dbf12qri